Nobiletin suppresses nasopharyngeal carcinoma by regulating the KEAP1/NRF2/ARE pathway
Acta Biochimica et Biophysica Sinica · 2025
DOI: 10.3724/abbs.2025113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Yiyao Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respira…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Nasopharyngeal Carcinoma, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Affiliated Tra…
- Guangdong Xinbaotang Biological Technology Co., Ltd., Jiangmen 529100, China.
- School of Public Health, Guangzhou Medical University, Guangzhou 511436, China.
Zitieren
APA
Liang, Y., Wei, M., Yao, Y., Chen, B., Deng, J., Xu, S., Li, L., Liu, W., Cai, Y., & Zheng, G. (2025). Nobiletin suppresses nasopharyngeal carcinoma by regulating the KEAP1/NRF2/ARE pathway. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025113
Vancouver
Liang Y, Wei M, Yao Y, Chen B, Deng J, Xu S, et al. Nobiletin suppresses nasopharyngeal carcinoma by regulating the KEAP1/NRF2/ARE pathway. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025113
BibTeX
@article{Liang2025,
author = {Liang, Yiyao and Wei, Minyan and Yao, Yunan and Chen, Baizhong and Deng, Jinji and Xu, Shiqi and Li, Liming and Liu, Wen and Cai, Yi and Zheng, Guodong},
title = {Nobiletin suppresses nasopharyngeal carcinoma by regulating the KEAP1/NRF2/ARE pathway},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2025113}
}
EUVIMED